TY  - JOUR

T1  - Phase I trial of DNA methyltransferase inhibitor guadecitabine combined with cisplatin and gemcitabine for solid malignancies including urothelial carcinoma (SPIRE)

JO  - Clinical Cancer Research

PY  - 2021/01/20

AU  - Crabb SJ

AU  - Danson S

AU  - Catto JWF

AU  - Hussain S

AU  - Chan D

AU  - Dunkley D

AU  - Downs N

AU  - Marwood E

AU  - Day L

AU  - Saunders G

AU  - Light M et al

ED  - 

DO  - DOI: 10.1158/1078-0432.ccr-20-3946

PB  - American Association for Cancer Research (AACR)

VL  - 27

IS  - 7

SP  - 1882

EP  - 1892

Y2  - 2025/11/04

ER  -